| Q38046917 | "Physiological" renal regenerating medicine in VLBW preterm infants: could a dream come true? |
| Q35108905 | Accelerated maturation and abnormal morphology in the preterm neonatal kidney. |
| Q39062499 | Acute kidney injury in the fetus and neonate |
| Q38723460 | Assessment of kidney function in preterm infants: lifelong implications |
| Q57794625 | Biochemistry, hormones and adipocytokines in prepubertal children born with IUGR evoke metabolic, hepatic and renal derangements |
| Q24303425 | CD10 in the developing human kidney: immunoreactivity and possible role in renal embryogenesis |
| Q37885585 | Can we predict hypertension among preterm children? |
| Q38019028 | Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants |
| Q53468584 | Decreasing podocyte number during human kidney intrauterine development. |
| Q47554079 | Development of the Human Fetal Kidney from Mid to Late Gestation in Male and Female Infants. |
| Q36969401 | Directed differentiation of pluripotent stem cells to kidney cells |
| Q36776390 | Drug-induced acute kidney injury in neonates |
| Q35993944 | Effects of ibuprofen treatment on the developing preterm baboon kidney. |
| Q26829452 | Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology |
| Q36936621 | Fetal kidney length as a useful adjunct parameter for better determination of gestational age. |
| Q39329153 | Immunohistochemical and electronmicroscopic features of mesenchymal-to-epithelial transition in human developing, postnatal and nephrotic podocytes |
| Q44321061 | Impact of small-for-gestational age (SGA) status on gentamicin pharmacokinetics in neonates |
| Q61847205 | Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury |
| Q37290080 | Longitudinal assessment of renal size and function in extremely low birth weight children at 7 and 11 years of age. |
| Q40009085 | Longitudinal patterns of urine biomarkers in infants across gestational ages |
| Q35902711 | Mammalian kidney development: principles, progress, and projections |
| Q57156418 | Maternal and environmental risk factors for neonatal AKI and its long-term consequences |
| Q26770384 | Modeling Kidney Disease with iPS Cells |
| Q34207078 | Morphogenesis and molecular mechanisms involved in human kidney development. |
| Q51852105 | Nephron formation adopts a novel spatial topology at cessation of nephrogenesis. |
| Q30457363 | Nephron number and its determinants in early life: a primer |
| Q64072894 | Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study |
| Q35994139 | Proteomic profiling of aging in glomeruli of mice by using two-dimensional differential gel electrophoresis |
| Q37599565 | Repair after nephron ablation reveals limitations of neonatal neonephrogenesis |
| Q48127999 | Serum creatinine during physiological perinatal dehydration may estimate individual nephron endowment |
| Q92829537 | Shaping of the nephron - a complex, vulnerable, and poorly explored backdrop for noxae impairing nephrogenesis in the fetal human kidney |
| Q96022604 | Spatio-temporal patterning of different connexins in developing and postnatal human kidneys and in nephrotic syndrome of the Finnish type (CNF) |
| Q54016287 | The Impact of Kidney Development on the Life Course: A Consensus Document for Action |
| Q38161817 | The interplay between drugs and the kidney in premature neonates. |
| Q37988805 | The long-term renal and cardiovascular consequences of prematurity |
| Q46334870 | The role of oxidative stress in acute renal injury of newborn rats exposed to hypoxia and endotoxin |
| Q43893775 | Toward nephrogenesis in the pig kidney: the composite tubulo-glomerular nodule. |
| Q38639117 | Ultrasound Imaging of the Renal Parenchyma of Premature Neonates for the Assessment of Renal Growth and Glomerulomegaly |
| Q89410254 | Umbilical artery histomorphometry: a link between the intrauterine environment and kidney development |